219 related articles for article (PubMed ID: 27172249)
1. Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.
Meseure D; Vacher S; Lallemand F; Alsibai KD; Hatem R; Chemlali W; Nicolas A; De Koning L; Pasmant E; Callens C; Lidereau R; Morillon A; Bieche I
Br J Cancer; 2016 Jun; 114(12):1395-404. PubMed ID: 27172249
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer.
Goyal B; Yadav SRM; Awasthee N; Gupta S; Kunnumakkara AB; Gupta SC
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188502. PubMed ID: 33428963
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
Xu S; Sui S; Zhang J; Bai N; Shi Q; Zhang G; Gao S; You Z; Zhan C; Liu F; Pang D
Int J Clin Exp Pathol; 2015; 8(5):4881-91. PubMed ID: 26191181
[TBL] [Abstract][Full Text] [Related]
5. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
6. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
8. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
9. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
11. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
Sun Z; Liu J; Liu J
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells.
Stone JK; Kim JH; Vukadin L; Richard A; Giannini HK; Lim SS; Tan M; Ahn EE
J Biol Chem; 2019 Jul; 294(29):11213-11224. PubMed ID: 31167784
[TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA Malat1: Its physiological and pathophysiological functions.
Zhang X; Hamblin MH; Yin KJ
RNA Biol; 2017 Dec; 14(12):1705-1714. PubMed ID: 28837398
[TBL] [Abstract][Full Text] [Related]
17. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
[TBL] [Abstract][Full Text] [Related]
18. Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis.
Cardamone G; Paraboschi EM; Soldà G; Cantoni C; Supino D; Piccio L; Duga S; Asselta R
Hum Mol Genet; 2019 May; 28(9):1414-1428. PubMed ID: 30566690
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Zheng L; Zhang Y; Fu Y; Gong H; Guo J; Wu K; Jia Q; Ding X
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683807
[TBL] [Abstract][Full Text] [Related]
20. MALAT1 promotes angiogenesis of breast cancer.
Huang XJ; Xia Y; He GF; Zheng LL; Cai YP; Yin Y; Wu Q
Oncol Rep; 2018 Nov; 40(5):2683-2689. PubMed ID: 30226550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]